Background: Somatic symptoms, such as chronic pain, fatigue, and gastrointestinal disturbances, are commonly reported in individuals with a history of childhood maltreatment (CM), which includes various forms of abuse and neglect experienced before age 18. Although CM is strongly associated with somatic symptoms, the specific relationships between CM subtypes and these symptoms, as well as the mechanisms connecting them, remain insufficiently understood. This review examines the complex interaction between CM and somatic symptoms, which often coexist with mental disorders and significantly impact quality of life and healthcare systems. Summary: Somatic symptoms, frequently a mix of “explained” and “unexplained” conditions, are associated with personal distress and pose diagnostic challenges. CM has been linked to these symptoms through neurobiological mechanisms, such as HPA axis dysregulation and allostatic load, while theoretical models emphasize the roles of hyperawareness, cultural factors, and vulnerability in symptom development. However, existing research often fails to account for specific CM subtypes, the full range of somatic symptoms, and cultural and situational factors, leading to inconsistencies in findings. Key Messages: Bridging gaps in literature requires adopting the World Health Organization’s CM subtype definitions and ICD-11 codes (MA00-MH2Y) to encompass a broader spectrum of somatic symptoms. Employing rigorous methodologies, such as systematic reviews and meta-analyses, is essential for advancing understanding. These approaches can enhance diagnostic accuracy, support tailored interventions, and promote a biopsychosocial framework for CM research, ultimately improving patient outcomes and alleviating societal burdens.

Childhood maltreatment (CM), including all forms of abuse and neglect – physical and/or emotional ill-treatment, sexual abuse, neglect, and commercial or other forms of exploitation – directed toward a child below the age of 18, is a significant public health concern, affecting up to 36% of the population worldwide [1‒3]. CM has frequently been associated with long-lasting mental and physical health consequences and greater utilization of healthcare services [4, 5]. For example, CM has been linked to mental disorders such as depressive disorders, anxiety, posttraumatic stress disorder, dissociative, bipolar, and psychotic disorders [6‒9]. CM has also been linked to various somatic diseases such as diabetes, cancer, and coronary heart disease [4, 10‒12], as well as medically explained or unexplained bodily symptoms such as chronic pain [13], including headaches [14].

The term “somatic” originates from the Greek word “soma,” meaning “body.” Somatic symptoms refer to bodily experiences that an individual perceives as deviations from normal health, such as pain, fatigue, changes in appetite, gastrointestinal issues, or neurological problems [15]. Somatic symptoms may or may not be linked to an underlying medical condition; they can arise from changes in bodily function, result from a specific disease, or be a consequence of emotional or psychological distress [15]. Somatic symptoms such as pain or fatigue or gastrointestinal problems are commonly observed both in childhood and adulthood among individuals affected by CM [16‒20], and can lead to significant personal distress, disability, as well as an increased burden on the healthcare system, and elevated healthcare costs [21, 22]. It is therefore crucial to understand the possible associations between these symptoms and CM and to elucidate putative pathways linking CM and bodily symptoms. In this state-of-the-art review, we examine current understanding of the associations between CM and somatic symptoms, highlight gaps in the literature, and propose directions for future research.

The term “somatic symptom” is commonly used in the literature to refer to symptoms lacking a clear medical explanation. However, the distinction between “medically explained” and “medically unexplained” conditions poses a significant challenge in healthcare settings [23, 24]. Patients often present with a mix of both “explained” and “unexplained” symptoms [24, 25], and there are often both physical and psychological etiological factors present [23, 26]. While some symptoms may be well explained by a medical condition (e.g., pneumonia) and resolved with adequate treatment (e.g., antibiotics), for a large array of symptoms the underlying contributor or cause might not always be clear. Receiving a specific diagnosis is determined by clinical judgment [27], cultural context [28], and clinical and laboratory tests, among other considerations. Additionally, symptoms considered “explained” and “unexplained” often coexist within the same patient [24, 25] and, in the case of chronic pain, do not seem to differ in terms of treatment response to cognitive-behavioral therapy [29]. It is thus preferable to refrain from artificially distinguishing somatic symptoms based on whether they are medically explained or not.

Somatic symptoms, such as pain or fatigue, or appetite changes often accompany a mental disorder, especially in affective and anxiety disorders [30, 31], and may negatively impact the course of depression [32]. Additionally, somatic symptoms constitute a core clinical feature of certain disorders like somatic symptom disorders, and functional neurological or gastrointestinal disorders. Both the International Classification of Diseases (ICD-11) and the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) cover diagnostic categories that specifically address somatic symptom and related syndromes [33, 34]. Approximately 30–40% of patients seeking medical attention, many of whom present with somatic complaints such as pain or fatigue or gastrointestinal, or neurological symptoms, have normal laboratory and imaging tests and will have their symptoms labeled in various ways, including but not limited to medically unexplained symptoms, somatization, conversion, functional symptoms, or somatoform symptoms [17‒19, 35, 36]. However, many patients experience waxing and waning symptoms, such as pain or dizziness that cannot be characterized by typical functional syndromes (e.g., irritable bowel syndrome) [37], or may not fully meet criteria for a somatic symptom disorder according to ICD-11 or “somatic symptom and related disorder” in the DSM-5-TR.

Nevertheless, there is a consensus among experts that somatic symptoms are characterized by personal distress and impaired quality of life [38] and may lead to negative affective states such as frustration and helplessness for both patients and medical staff [39]. Given that these symptoms cause significant personal distress, disability, increase the service burden of the healthcare system, and impose high healthcare costs, it is important to better understand the factors underlying the development and maintenance of somatic symptoms [21, 22].

CM has consistently been associated with somatic consequences such as an enhanced risk of several illnesses including non-communicable diseases such as diabetes and cancer [4, 9, 11]. Large epidemiological data suggest associations of CM with adult diseases including ischemic heart disease, cancer, chronic lung disease, skeletal fractures, and liver disease and even increased mortality [40‒42]. Notably, adults with a history of CM are often present in primary care settings, where healthcare providers frequently face challenges with symptoms that do not meet the diagnostic criteria for specific medical conditions. This can lead to treatment delays and negatively impact treatment outcomes for individuals with CM, resulting in distress and frustration for both patients and medical staff [35, 36, 38, 39, 43].

Several theoretical models have been proposed to understand the underlying mechanisms involved in the genesis of somatic symptoms [44‒47]. For example, Barsky and Wyshak [48] developed the somatosensory amplification model, which suggests that individuals who are especially sensitive to threat-related cues tend to become hyperaware of their own bodily sensations and misinterpret them as signs of a medical condition. Löwe and Gerloff [49] have highlighted that several authors have extended this model by adding vulnerability factors (e.g., CM, cultural beliefs) and mediating factors (e.g., education, avoidance) that help explain the development and perception of somatic symptoms [44, 45].

The abovementioned theoretical models of somatic symptoms are underpinned by research examining neurobiological pathways associated with adverse experiences such as CM. Among these, the most discussed in the context of CM involve pathways associated with reward, threat, and somatosensory mechanisms [50, 51], hormonal systems such as the hypothalamic-pituitary-adrenal axis, and epigenetic mechanisms [52, 53]. Repeated activation of these systems and pathways in individuals exposed to chronic stressors including CM might be adaptive in the beginning but can contribute to allostatic overload, i.e., the cumulative “wear and tear” on the body’s systems [54, 55].

CM has been found to predict allostatic load [56] and high allostatic load has repeatedly been associated with poor physical health [57, 58]. As an example, Putnam’s consecutive work provided evidence of allostatic load concept triggered by CM, demonstrating that females with histories of childhood sexual abuse experience increased healthcare use due to HPA dysregulation, manifested in preterm delivery, obesity, and gynecological issues [59]. Recently, a study conducted by Barends and colleagues [60] found that cumulative exposure to potentially traumatic events including CM was associated with a higher burden of persistent somatic symptoms which supports the concept of allostatic load [61].

There is a strong consensus and substantial data supporting an association between what has often been summarized as functional somatic symptoms on the one hand and traumatic experiences including CM on the other hand [37, 60, 62, 63]. However, despite this evidence, gaps persist in literature. Below, each identified gap is followed by a research direction to address it.

Gap 1

There is some inconsistency in the literature regarding the specific impact of various subtypes of CM on the development of somatic symptoms. Several studies have found associations of physical [64] and sexual abuse [65] with somatic symptoms development. Recent research by Eilers and colleagues [66] has extended these findings, suggesting that emotional abuse, as well as physical and emotional neglect, may also be relevant to the experience of somatic symptoms. Conversely, some studies have only found associations between somatic symptoms and specific subtypes of CM, such as emotional abuse [67] or physical abuse [68], but not with other types of CM. To the best of our knowledge, these somewhat inconsistent findings regarding specific subtypes of CM have not yet been analyzed in a meta-analysis. While Afari and colleagues [62] conducted a meta-analysis that demonstrated significant effects of physical, sexual, and emotional abuse on the development of functional somatic symptoms, they did not address the impact of emotional or physical neglect.

Research Direction

One key recommendation is to define CM based on WHO standards, which categorize it into emotional, physical, and sexual abuse, as well as neglect experienced before age 18. According to the WHO [3], CM is classified into several subtypes, which may slightly differ in how they impact an individual’s short- and long-term health [51, 69]. Studies including both abuse and neglect experiences provide insight into how these similar, yet distinct experiences are associated with somatic symptoms. This approach is critical for current and future therapeutic strategies, particularly within the framework of personalized medicine. CM assessments, as a standard practice, can enhance diagnostic accuracy and support the development of personalized interventions. Ultimately, appreciating CM’s impact is crucial across the medical field, extending beyond mental health alone. Recognizing this connection between CM and health can improve diagnostic accuracy, treatment efficacy, and patient satisfaction, reducing frustration for both patients and healthcare providers.

Gap 2

Much of the existing literature narrows its focus to specific functional syndromes (e.g., fibromyalgia, chronic pain, irritable bowel syndrome, psychogenic non-epileptic seizures), or selected health outcomes (e.g., respiratory disease, heart disease, physical inactivity) rather than somatic symptoms as a broad category [62, 63, 70]. This may lead to an underrepresentation of individuals who do not meet the criteria for specific functional syndromes. Therefore, it remains unclear if, and how strongly, different subtypes of CM are associated with the development of somatic symptoms in adulthood. As a result, there is a gap in literature concerning the impact of CM on the development of somatic symptoms that extend beyond these functional syndromes.

Research Direction

This research direction has the potential to deepen biopsychosocial perspectives across medical fields and strengthen collaboration between medical specialties and mental health providers. When defining somatic symptoms, we suggest using the full range of bodily symptoms classified under ICD-11 codes MA00-MH2Y. Unlike previous studies [62, 63], this inclusive approach adopts a broader and more inclusive definition, moving beyond conventional terms and avoiding commonly used labels like medically unexplained symptoms, somatization, conversion, functional symptoms, or somatoform symptoms. By extending the scope to include all somatic consequences, artificial categorizations and unsupported labeling of symptoms without substantial evidence in etiology can be avoided. From a body-mind interaction perspective, this unique approach offers a deeper understanding of the impact of CM on adult somatic health, providing greater insights into how early life stressors influence long-term health outcomes. By establishing straightforward evidence of CM’s role in the development of diverse somatic symptoms – from subjective ones like pain or fatigue to more objective indicators like bleeding – CM can be recognized as a significant factor in various health conditions. Understanding CM’s impact on the body and routinely assessing CM experiences during psychosocial evaluations can empower healthcare providers to address these challenges more effectively, benefiting both patients and practitioners.

Gap 3

It is important to acknowledge the impact of cultural factors on both somatic symptoms, as well as the impact of CM itself. For example, cultural differences in parenting practices and societal norms can affect whether a specific behavior is labeled abusive or normative [71‒73]. There may also be barriers to reporting maltreatment due to concerns about family reputation or cultural norms that discourage speaking out against authorities [74]. Similarly, cultural factors can affect whether psychological distress is manifested as a somatic symptoms or emotional complaints [75‒77]. Moreover, beliefs about mental health and stigma can further shape how these somatic symptoms are then experienced and even treated within different communities [78]. To develop effective preventive measures and interventions for somatic symptoms, it is thus crucial to understand the influence of CM experiences and consider the role of culture.

Research Direction

Future research could not only focus on creating tailored interventions for diverse types of CM and somatic symptoms, but also consider potential cultural differences in how these symptoms are experienced and manifested. Beliefs about mental health and stigma can shape how somatic symptoms are experienced and treated within different communities [78], which highlight the importance of culturally informed practices, both in the medical and the psychological field. Acknowledging the influence of culture on somatic symptoms (e.g., whether psychological distress is manifested as a somatic symptom [75‒77] and CM (e.g., barriers to reporting) [74] is a first step toward more inclusive options including prevention, early identification, and treatment. Cultural influence on both somatic symptoms and CM should be explored through literature. Therefore, research in literature should be widened including a wide range of databases and languages. Moreover, beliefs about mental health and stigma and how these somatic symptoms are then experienced and even treated within different communities may be a target of research. Study groups should include a diversity of participants to enrich discussion and comprehension of findings.

In summary, while convincing evidence links CM with SS, inconsistencies remain regarding specific CM subtypes, and most meta-analyses have focused narrowly on certain health outcomes rather than somatic symptoms as a broad category. Furthermore, the influence of cultural factors on the CM-somatic symptoms relationship remains underexplored. Revisiting and addressing these gaps in literature could enhance understanding and guide more comprehensive future studies. A comprehensive and innovative approach to studying the CM-somatic symptoms link is essential.

A new research pathway should integrate inclusive definitions and cultural considerations to enhance our understanding of the CM-somatic symptoms relationship and its impact on healthcare strategies and patient outcomes. This integrated approach offers fresh insights into the mind-body connection, providing a review of existing literature and identifying key gaps in our understanding of the CM-somatic symptoms association, enhance awareness of the CM-physical health link among researchers and primary care providers who frequently work with individuals affected by CM and promises to foster communication and collaboration among medical disciplines, advancing holistic patient care [79, 80].

A systematic review and meta-analysis on CM experiences and somatic symptoms in adults would be a valuable first step to develop an evidence-based framework of CM-somatic symptoms associations, clarifying whether somatic symptoms are more frequent and severe in adults with a history of CM and exploring associations between CM and somatic symptoms. Authors have registered a meta-analysis protocol in this context to the PROSPERO system (International prospective register of systematic reviews) under the name of “Childhood Maltreatment and Somatic Symptoms in Adulthood: A systematic review and meta-analysis” and with the ID of 427738. In accordance with the abovementioned research directions, we recommend defining CM according to the WHO criteria and including somatic symptoms based on the full range of ICD-11 bodily symptoms (MA00-MH2Y), using these as keywords in the literature search. In addition, underlying pathways contributing to this connection should be analyzed by incorporating moderators like cultural context and CM subtypes. To ensure methodological rigor, such review should apply precise study selection and exclusion criteria, a comprehensive search strategy, and transparent data analysis protocols. Adherence to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement, the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) checklist, and the Enhancing the Quality and Transparency of Health Research (EQUATOR) guidelines will further strengthen the study’s reliability [81‒84].

Somatic symptoms are common in individuals with a history of CM. However, despite evidence of significant associations, the specific links between CM types and somatic symptoms, as well as the underlying mechanisms, remain unclear. This gap partly arises from the limited inclusion of diverse CM subtypes and the narrow definition of somatic symptoms, which often encompasses only medically unexplained symptoms rather than a full range of bodily symptoms. Research that further explores these associations, as well as factors like cultural influences shaping this interaction, is essential. A new research pathway could enhance understanding by categorizing CM subtypes based on WHO standards, broadening the definition of somatic symptoms to include the comprehensive symptom range under ICD-11 codes MA00-MH2Y, and identifying cultural and situational moderators (e.g., cultural beliefs, healthcare access) that shape somatic symptom presentation. As a first step, a systematic literature review grounded in these principles would provide a strong foundation for developing future research aimed at paving the way for preventive and therapeutic interventions.

The authors thank Koç University Library for providing its facilities.

The authors declare no conflict of interest.

This study was not supported by any sponsor or funder. The work by J.S.W. was made possible through funding by the South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the Early Investigators Programme from funding received from the South African National Treasury. The funders had no role in the study design or writing of the protocol.

A.M.L., G.A., N.E.F.-O., U.S., V.S., M.C.P., and D.C. contributed to the conceptualization and methodology development of the project. Project administration was led by A.M.L. and G.A. The initial manuscript draft was prepared by A.M.L., G.A., N.E.F.-O., K.L., M.H., L.P., D.C., T.T., and J.S.W. D.C. supervised the development of the protocol and manuscript and oversaw revisions based on reviewer feedback. All authors (A.M.L., G.A., R.B., J.C.-N., D.J.E., N.E.F.-O., M.H., N.I., D.J., S.K.S., K.L., N.M., C.M.-S., E.N., M.Oe., J.N.O., M.Ol., L.P., S.S., T.T., D.L.W., J.S.W., U.S., V.S., M.C.P., and D.C.) contributed to the manuscript revision and editing.

Additional Information

Antonia M. Lüönd and Görkem Ayas contributed equally to this work.

1.
Moody
G
,
Cannings-John
R
,
Hood
K
,
Kemp
A
,
Robling
M
.
Establishing the international prevalence of self-reported child maltreatment: a systematic review by maltreatment type and gender
.
BMC Public Health
.
2018
;
18
(
1
):
1164
.
2.
Stoltenborgh
M
,
Bakermans-Kranenburg
MJ
,
Alink
LRA
,
van IJzendoorn
MH
.
The prevalence of child maltreatment across the globe: review of a series of meta-analyses
.
Child Abuse Rev
.
2015
;
24
(
1
):
37
50
.
3.
World Health Organization
.
Child maltreatment
;
2022
. Available from: https://www.who.int/news-room/fact-sheets/detail/child-maltreatment
4.
Hughes
M
,
Cossar
J
.
The relationship between maternal childhood emotional abuse/neglect and parenting outcomes: a systematic review
.
Child Abuse Rev
.
2016
;
25
(
1
):
31
45
.
5.
Pfaltz
MC
,
Halligan
SL
,
Haim-Nachum
S
,
Sopp
MR
,
Åhs
F
,
Bachem
R
, et al
.
Social functioning in individuals affected by childhood maltreatment: establishing a research agenda to inform interventions
.
PPS
.
2022
;
91
(
4
):
238
51
.
6.
Gardner
MJ
,
Thomas
HJ
,
Erskine
HE
.
The association between five forms of child maltreatment and depressive and anxiety disorders: a systematic review and meta-analysis
.
Child Abuse Negl
.
2019
;
96
:
104082
.
7.
Şar
V
.
Childhood trauma and dissociative disorders
. In:
Spalletta
G
,
Janiri
D
,
Piras
F
,
Sani
G
, editors.
Childhood trauma in mental disorders: a comprehensive approach
.
Cham
:
Springer International Publishing
;
2020
[cited 2024 May 23]. p.
333
65
.
8.
Arat-Çelik
HE
,
Tuna
G
,
Kök-Kendirlioğlu
B
,
Çörekli
E
,
Yorguner
N
,
Teke
Z
, et al
.
Childhood trauma and neurocognitive functions in individuals with bipolar disorder and unaffected siblings of individuals with bipolar disorder
.
Neurosci Appl
.
2023
;
2
:
101138
.
9.
Warrier
V
,
Kwong
ASF
,
Luo
M
,
Dalvie
S
,
Croft
J
,
Sallis
HM
, et al
.
Gene-environment correlations and causal effects of childhood maltreatment on physical and mental health: a genetically informed approach
.
Lancet Psychiatr
.
2021
;
8
(
5
):
373
86
.
10.
Clemens
V
,
Huber-Lang
M
,
Plener
PL
,
Brähler
E
,
Brown
RC
,
Fegert
JM
.
Association of child maltreatment subtypes and long-term physical health in a German representative sample
.
Eur J Psychotraumatol
.
2018
;
9
(
1
):
1510278
.
11.
Chen
Y
,
Shan
Y
,
Lin
K
,
Wei
Y
,
Kim
H
,
Koenen
KC
, et al
.
Association between child abuse and risk of adult coronary heart disease: a systematic review and meta-analysis
.
Am J Prev Med
.
2023
;
65
(
1
):
143
54
.
12.
Souama
C
,
Lamers
F
,
Milaneschi
Y
,
Vinkers
CH
,
Defina
S
,
Garvert
L
, et al
.
Depression, cardiometabolic disease, and their co-occurrence after childhood maltreatment: an individual participant data meta-analysis including over 200,000 participants
.
BMC Med
.
2023
;
21
(
1
):
93
.
13.
Bussières
A
,
Hancock
MJ
,
Elklit
A
,
Ferreira
ML
,
Ferreira
PH
,
Stone
LS
, et al
.
Adverse childhood experience is associated with an increased risk of reporting chronic pain in adulthood: a stystematic review and meta-analysis
.
Eur J Psychotraumatol
.
2023
;
14
(
2
):
2284025
.
14.
Sikorski
C
,
Mavromanoli
AC
,
Manji
K
,
Behzad
D
,
Kreatsoulas
C
.
Adverse childhood experiences and primary headache disorders: a systematic review, meta-analysis, and application of a biological theory
.
Neurology
.
2023
;
101
(
21
):
e2151
61
.
15.
Zijlema
WL
,
Stolk
RP
,
Löwe
B
,
Rief
W
;
BioSHaRE
;
White
PD
, et al
.
How to assess common somatic symptoms in large-scale studies: a systematic review of questionnaires
.
J Psychosom Res
.
2013
;
74
(
6
):
459
68
.
16.
Creed
F
,
Barsky
A
.
A systematic review of the epidemiology of somatisation disorder and hypochondriasis
.
J Psychosom Res
.
2004
;
56
(
4
):
391
408
.
17.
Kirmayer
LJ
,
Groleau
D
,
Looper
KJ
,
Dao
MD
.
Explaining medically unexplained symptoms
.
Can J Psychiatry
.
2004
;
49
(
10
):
663
72
.
18.
Kroenke
K
,
Mangelsdorff
AD
.
Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome
.
Am J Med
.
1989
;
86
(
3
):
262
6
.
19.
Simon
G
,
Gater
R
,
Kisely
S
,
Piccinelli
M
.
Somatic symptoms of distress: an international primary care study
.
Psychosom Med
.
1996
;
58
(
5
):
481
8
.
20.
Campo
JV
.
Annual research review: functional somatic symptoms and associated anxiety and depression--developmental psychopathology in pediatric practice
.
J Child Psychol Psychiatry
.
2012
;
53
(
5
):
575
92
.
21.
Jadhakhan
F
,
Romeu
D
,
Lindner
O
,
Blakemore
A
,
Guthrie
E
.
Prevalence of medically unexplained symptoms in adults who are high users of healthcare services and magnitude of associated costs: a systematic review
.
BMJ Open
.
2022
;
12
(
10
):
e059971
.
22.
McAndrew
LM
,
Phillips
LA
,
Helmer
DA
,
Maestro
K
,
Engel
CC
,
Greenberg
LM
, et al
.
High healthcare utilization near the onset of medically unexplained symptoms
.
J Psychosom Res
.
2017
;
98
:
98
105
.
23.
Klaus
K
,
Rief
W
,
Brähler
E
,
Martin
A
,
Glaesmer
H
,
Mewes
R
.
The distinction between “medically unexplained” and “medically explained” in the context of somatoform disorders
.
Int J Behav Med
.
2013
;
20
(
2
):
161
71
.
24.
Leiknes
KA
,
Finset
A
,
Moum
T
,
Sandanger
I
.
Course and predictors of medically unexplained pain symptoms in the general population
.
J Psychosom Res
.
2007
;
62
(
2
):
119
28
.
25.
Fink
P
.
Physical complaints and symptoms of somatizing patients
.
J Psychosom Res
.
1992
;
36
(
2
):
125
36
.
26.
Kroenke
K
,
Lucas
CA
,
Rosenberg
ML
,
Scherokman
B
,
Herbers
JE
,
Wehrle
PA
, et al
.
Causes of persistent dizziness. A prospective study of 100 patients in ambulatory care
.
Ann Intern Med
.
1992
;
117
(
11
):
898
904
.
27.
Fink
P
,
Rosendal
M
,
Olesen
F
.
Classification of somatization and functional somatic symptoms in primary care
.
Aust N Z J Psychiatry
.
2005
;
39
(
9
):
772
81
.
28.
Rief
W
,
Martin
A
.
How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications
.
Annu Rev Clin Psychol
.
2014
;
10
:
339
67
.
29.
McNaughton
DT
,
Hush
JM
,
Beath
AP
,
Gandy
M
,
Dear
BF
,
Jones
MP
.
Whether chronic pain is medically explained or not does not moderate the response to cognitive-behavioural therapy
.
J Psychosom Res
.
2019
;
121
:
29
36
.
30.
Löwe
B
,
Spitzer
RL
,
Williams
JBW
,
Mussell
M
,
Schellberg
D
,
Kroenke
K
.
Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment
.
Gen Hosp Psychiatry
.
2008
;
30
(
3
):
191
9
.
31.
Steinbrecher
N
,
Koerber
S
,
Frieser
D
,
Hiller
W
.
The prevalence of medically unexplained symptoms in primary care
.
Psychosomatics
.
2011
;
52
(
3
):
263
71
.
32.
Huijbregts
KML
,
van der Feltz-Cornelis
CM
,
van Marwijk
HWJ
,
de Jong
FJ
,
van der Windt
DAWM
,
Beekman
ATF
.
Negative association of concomitant physical symptoms with the course of major depressive disorder: a systematic review
.
J Psychosom Res
.
2010
;
68
(
6
):
511
9
.
33.
World Health Organization
.
ICD-11
;
2022
[cited 2024 May 23]. Available from: https://icd.who.int/en
34.
Diagnostic and statistical manual of mental disorders: DSM-5TM
. 5th ed.
Arlington, VA, USA
:
American Psychiatric Publishing, Inc.
;
2013
. p.
xliv, 947
.
35.
Haller
H
,
Cramer
H
,
Lauche
R
,
Dobos
G
.
Somatoform disorders and medically unexplained symptoms in primary care
.
Dtsch Arztebl Int
.
2015
;
112
(
16
):
279
87
.
36.
Nimnuan
C
,
Hotopf
M
,
Wessely
S
.
Medically unexplained symptoms: an epidemiological study in seven specialities
.
J Psychosom Res
.
2001
;
51
(
1
):
361
7
.
37.
Roelofs
K
,
Spinhoven
P
.
Trauma and medically unexplained symptoms: towards an integration of cognitive and neuro-biological accounts
.
Clin Psychol Rev
.
2007
;
27
(
7
):
798
820
.
38.
Dirkzwager
AJ
,
Verhaak
PF
.
Patients with persistent medically unexplained symptoms in general practice: characteristics and quality of care
.
BMC Fam Pract
.
2007
;
8
(
1
):
33
.
39.
Mariman
A
,
Vermeir
P
,
Csabai
M
,
Weiland
A
,
Stegers-Jager
K
,
Vermeir
R
, et al
.
Education on medically unexplained symptoms: a systematic review with a focus on cultural diversity and migrants
.
Eur J Med Res
.
2023
;
28
(
1
):
145
.
40.
World Health Organization
.
Noncommunicable diseases progress monitor 2020
;
2020
[cited 2024 May 23]. Available from: https://www.who.int/publications-detail-redirect/9789240000490
41.
Felitti
VJ
,
Anda
RF
,
Nordenberg
D
,
Williamson
DF
,
Spitz
AM
,
Edwards
V
, et al
.
Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study
.
Am J Prev Med
.
1998
;
14
(
4
):
245
58
.
42.
Morse
M
,
Strompolis
M
,
Srivastav
A
.
The adverse childhood experiences study: lessons learned and future directions
;
2018
. Available from: https://scchildren.org/
43.
García-Campayo
J
,
Ayuso-Mateos
JL
,
Caballero
L
,
Romera
I
,
Aragonés
E
,
Rodríguez-Artalejo
F
, et al
.
Relationship of somatic symptoms with depression severity, quality of life, and health resources utilization in patients with major depressive disorder seeking primary health care in Spain
.
Prim Care Companion J Clin Psychiatry
.
2008
;
10
(
5
):
355
62
.
44.
Brown
RJ
.
Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model
.
Psychol Bull
.
2004
;
130
(
5
):
793
812
.
45.
Henningsen
P
,
Zipfel
S
,
Sattel
H
,
Creed
F
.
Management of functional somatic syndromes and bodily distress
.
Psychother Psychosom
.
2018
;
87
(
1
):
12
31
.
46.
Kearney
BE
,
Lanius
RA
.
The brain-body disconnect: a somatic sensory basis for trauma-related disorders
.
Front Neurosci
.
2022
;
16
:
1015749
.
47.
Rief
W
,
Broadbent
E
.
Explaining medically unexplained symptoms-models and mechanisms
.
Clin Psychol Rev
.
2007
;
27
(
7
):
821
41
.
48.
Barsky
AJ
,
Wyshak
G
.
Hypochondriasis and somatosensory amplification
.
Br J Psychiatry
.
1990
;
157
:
404
9
.
49.
Löwe
B
,
Gerloff
C
.
Functional somatic symptoms across cultures: perceptual and health care issues
.
Psychosom Med
.
2018
;
80
(
5
):
412
5
.
50.
Cay
M
,
Gonzalez-Heydrich
J
,
Teicher
MH
,
Van Der Heijden
H
,
Ongur
D
,
Shinn
AK
, et al
.
Childhood maltreatment and its role in the development of pain and psychopathology
.
Lancet Child Adolesc Health
.
2022
;
6
(
3
):
195
206
.
51.
Teicher
MH
,
Samson
JA
.
Annual Research Review: enduring neurobiological effects of childhood abuse and neglect
.
J Child Psychol Psychiatry
.
2016
;
57
(
3
):
241
66
.
52.
Buffington
CAT
.
Developmental influences on medically unexplained symptoms
.
Psychother Psychosom
.
2009
;
78
(
3
):
139
44
.
53.
McCrory
E
,
De Brito
SA
,
Viding
E
.
Research review: the neurobiology and genetics of maltreatment and adversity
.
J Child Psychol Psychiatry
.
2010
;
51
(
10
):
1079
95
.
54.
Pfaltz
MC
,
Schnyder
U
.
Allostatic load and allostatic overload: preventive and clinical implications
.
Psychother Psychosom
.
2023
;
92
(
5
):
279
82
.
55.
McEwen
BS
,
Stellar
E
.
Stress and the individual: mechanisms leading to disease
.
Arch Intern Med
.
1993
;
153
(
18
):
2093
101
.
56.
Widom
CS
,
Horan
J
,
Brzustowicz
L
.
Childhood maltreatment predicts allostatic load in adulthood
.
Child Abuse Negl
.
2015
;
47
:
59
69
.
57.
Guidi
J
,
Lucente
M
,
Sonino
N
,
Fava
GA
.
Allostatic load and its impact on health: a systematic review
.
Psychother Psychosom
.
2021
;
90
(
1
):
11
27
.
58.
Juster
RP
,
McEwen
BS
,
Lupien
SJ
.
Allostatic load biomarkers of chronic stress and impact on health and cognition
.
Neurosci Biobehav Rev
.
2010
;
35
(
1
):
2
16
.
59.
Trickett
PK
,
Noll
JG
,
Putnam
FW
.
The impact of sexual abuse on female development: lessons from a multigenerational, longitudinal research study
.
Dev Psychopathol
.
2011
;
23
(
2
):
453
76
.
60.
Barends
H
,
van der Wouden
JC
,
Claassen-van Dessel
N
,
Twisk
JWR
,
van der Horst
HE
,
Dekker
J
.
Potentially traumatic events, social support and burden of persistent somatic symptoms: a longitudinal study
.
J Psychosom Res
.
2022
;
159
:
110945
.
61.
Pfaltz
MC
,
Schnyder
U
.
Allostatic load and allostatic overload: preventive and clinical implications
.
Psychother Psychosom
.
2023
;
92
(
5
):
279
82
.
62.
Afari
N
,
Ahumada
SM
,
Wright
LJ
,
Mostoufi
S
,
Golnari
G
,
Reis
V
, et al
.
Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis
.
Psychosom Med
.
2014
;
76
(
1
):
2
11
.
63.
Paras
ML
,
Murad
MH
,
Chen
LP
,
Goranson
EN
,
Sattler
AL
,
Colbenson
KM
, et al
.
Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis
.
JAMA
.
2009
;
302
(
5
):
550
61
.
64.
Nelson
S
,
Baldwin
N
,
Taylor
J
.
Mental health problems and medically unexplained physical symptoms in adult survivors of childhood sexual abuse: an integrative literature review
.
J Psychiatr Ment Health Nurs
.
2012
;
19
(
3
):
211
20
.
65.
Duncan
R
,
Mulder
R
,
Wilkinson
SH
,
Horwood
J
.
Medically unexplained symptoms and antecedent sexual abuse: an observational study of a birth cohort
.
Psychosom Med
.
2019
;
81
(
7
):
622
8
.
66.
Eilers
H
,
aan het Rot
M
,
Jeronimus
BF
.
Childhood trauma and adult somatic symptoms
.
Psychosom Med
.
2023
;
85
(
5
):
408
16
.
67.
Adamowicz
JL
,
Sirotiak
Z
,
Thomas
EBK
.
Childhood maltreatment and somatic symptoms: examining the role of specific types of childhood maltreatment and alexithymia
.
Psychol Trauma
.
2024
;
16
(
Suppl 1
):
S2
9
. No Pagination Specified-No Pagination Specified.
68.
Lamahewa
K
,
Buszewicz
M
,
Walters
K
,
Marston
L
,
Nazareth
I
.
Persistent unexplained physical symptoms: a prospective longitudinal cohort study in UK primary care
.
Br J Gen Pract
.
2019
;
69
(
681
):
e246
53
.
69.
McLaughlin
KA
,
Sheridan
MA
,
Lambert
HK
.
Childhood adversity and neural development: deprivation and threat as distinct dimensions of early experience
.
Neurosci Biobehav Rev
.
2014
;
47
:
578
91
.
70.
Hughes
K
,
Bellis
MA
,
Hardcastle
KA
,
Sethi
D
,
Butchart
A
,
Mikton
C
, et al
.
The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis
.
Lancet Public Health
.
2017
;
2
(
8
):
e356
66
.
71.
Wadji
DL
,
Oe
M
,
Cheng
P
,
Bartoli
E
,
Martin-Soelch
C
,
Pfaltz
MC
, et al
.
Associations between experiences of childhood maltreatment and perceived acceptability of child maltreatment: a cross-cultural and exploratory study
.
Child Abuse Negl
.
2023
;
143
:
106270
.
72.
Wadji
DL
,
Oe
M
,
Bartoli
E
,
Martin-Soelch
C
,
Pfaltz
MC
,
Langevin
R
.
How are experiences and acceptability of child maltreatment related to resilience and posttraumatic growth: a cross cultural study
.
Eur J Psychotraumatol
.
2023
;
14
(
2
):
2264119
.
73.
Klika
JB
,
Haboush-Deloye
A
,
Linkenbach
J
.
Hidden protections: identifying social norms associated with child abuse, sexual abuse, and neglect
.
Child Adolesc Soc Work J
.
2019
;
36
(
1
):
5
14
.
74.
Fontes
LA
,
Plummer
C
.
Cultural issues in disclosures of child sexual abuse
.
J Child Sex Abus
.
2010
;
19
(
5
):
491
518
.
75.
Barbati
A
,
Geraci
A
,
Niro
F
,
Pezzi
L
,
Sarchiapone
M
.
Do migration and acculturation impact somatization? A scoping review
.
Int J Environ Res Public Health
.
2022
;
19
(
23
):
16011
.
76.
Kleinman
AM
.
Depression, somatization and the “new cross-cultural psychiatry”
.
Soc Sci Med
.
1977
;
11
(
1
):
3
10
.
77.
Ryder
AG
,
Chentsova-Dutton
YE
.
Depression in cultural context: “Chinese somatization,” revisited
.
Psychiatr Clin North Am
.
2012
;
35
(
1
):
15
36
.
78.
Kirmayer
LJ
,
Sartorius
N
.
Cultural models and somatic syndromes
.
Psychosom Med
.
2007
;
69
(
9
):
832
40
.
79.
Arnow
BA
,
Hart
S
,
Hayward
C
,
Dea
R
,
Barr Taylor
C
.
Severity of child maltreatment, pain complaints and medical utilization among women
.
J Psychiatr Res
.
2000
;
34
(
6
):
413
21
.
80.
Newman
MG
,
Clayton
L
,
Zuellig
A
,
Cashman
L
,
Arnow
B
,
Dea
R
, et al
.
The relationship of childhood sexual abuse and depression with somatic symptoms and medical utilization
.
Psychol Med
.
2000
;
30
(
5
):
1063
77
.
81.
Moher
D
,
Shamseer
L
,
Clarke
M
,
Ghersi
D
,
Liberati
A
,
Petticrew
M
, et al
.
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
.
Syst Rev
.
2015
;
4
(
1
):
1
.
82.
Shamseer
L
,
Moher
D
,
Clarke
M
,
Ghersi
D
,
Liberati
A
,
Petticrew
M
, et al
.
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
.
BMJ
.
2015
;
350
:
g7647
.
83.
Stroup
DF
,
Berlin
JA
,
Morton
SC
,
Olkin
I
,
Williamson
GD
,
Rennie
D
, et al
.
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group
.
JAMA
.
2000
;
283
(
15
):
2008
12
.
84.
Altman
DG
,
Simera
I
,
Hoey
J
,
Moher
D
,
Schulz
K
.
EQUATOR: reporting guidelines for health research
.
Lancet
.
2008
;
371
(
9619
):
1149
50
.